Search for Clinical Trial Results

Sponsored By

Exocrine Pancreatic Insufficiency - 27 Studies Found

Status Study
Completed Study Name: An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)
Condition: Exocrine Pancreatic Insufficiency
Date: 2007-11-14
Interventions: Drug: VIOKASE 16 The VIOKASE 16 is to be taken as 3 tablets with the perfusion procedure.
Completed Study Name: Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.
Condition: Exocrine Pancreatic Insufficiency: Cystic Fibrosis
Date: 2012-07-10
Interventions:
  • Drug: EUR-1008 25,000 Units EU
Completed Study Name: A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)
Condition:
  • Chronic Pancreatitis
  • Exocrine Pancreatic Insufficiency
    • Date: 2008-11-10
    Interventions:
    • Drug: Placebo Placebo matching
Completed Study Name: Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Condition:
  • Cystic Fibrosis
  • Exocrine Pancreatic Insufficiency

Date: 2007-03-19
Interventions:
  • Drug: Liprotamase Administered
Completed Study Name: Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Condition: Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
Date: 2015-03-19
Interventions:
  • Drug: Creon IR
  • Drug: Creon® (DR/GR)
Withdrawn Study Name: A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2
Condition: Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2
Date: 2013-11-25
Interventions:
  • Drug: Creon Creon 25000 (2 cap
Completed Study Name: Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
Condition:
  • Cystic Fibrosis
  • Exocrine Pancreatic Insufficiency

Date: 2009-09-21
Interventions: Drug: EUR-1008 (APT-1008) EUR-1008 (APT-1008) Microtabs contained in a capsule will be administered oral
Completed Study Name: A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency
Condition: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
Date: 2006-11-16
Interventions:
  • Drug: SA-001 0.25 g of SA-001

Completed Study Name: Pancreatic Insufficiency Secondary to Tobacco Exposure
Condition: Pancreatic Insufficiency
Date: 2013-07-24
Completed Study Name: Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
Condition:
  • Cystic Fibrosis
  • Exocrine Pancreatic Insufficiency

Date: 2006-02-27
Interventions:
  • Drug: EUR-1008 (APT-1008) EUR-
Next >>>